As opposed to what was observed when CD34 immunostaining was employed, in tumors with high-intensity tumor budding, we did not observe differences in MVD, assessed by CD105 immunostaining, between the budding area and the area outside the budding. The gene discussed is ENG; the disease is neoplasm.